Annual CFF
$519.75 M
+$269.72 M+107.88%
December 31, 2024
Summary
- As of March 13, 2025, BCYC annual cash flow from financing activities is $519.75 million, with the most recent change of +$269.72 million (+107.88%) on December 31, 2024.
- During the last 3 years, BCYC annual CFF has risen by +$199.03 million (+62.05%).
- BCYC annual CFF is now at all-time high.
Performance
BCYC Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$203.00 K
+$32.13 M+100.64%
December 31, 2024
Summary
- As of March 13, 2025, BCYC quarterly cash flow from financing activities is $203.00 thousand, with the most recent change of +$32.13 million (+100.64%) on December 31, 2024.
- Over the past year, BCYC quarterly CFF has dropped by -$549.40 million (-99.96%).
- BCYC quarterly CFF is now -99.96% below its all-time high of $549.61 million, reached on June 30, 2024.
Performance
BCYC Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$519.75 M
-$183.00 K-0.04%
December 31, 2024
Summary
- As of March 13, 2025, BCYC TTM cash flow from financing activities is $519.75 million, with the most recent change of -$183.00 thousand (-0.04%) on December 31, 2024.
- Over the past year, BCYC TTM CFF has dropped by -$266.74 million (-33.92%).
- BCYC TTM CFF is now -33.92% below its all-time high of $786.49 million, reached on June 30, 2024.
Performance
BCYC TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
BCYC Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +107.9% | -100.0% | -33.9% |
| 3 y3 years | +62.0% | -100.0% | -33.9% |
| 5 y5 years | +789.4% | -100.0% | -33.9% |
BCYC Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +7666.7% | -100.0% | +100.6% | -33.9% | +7666.7% |
| 5 y | 5-year | at high | +7666.7% | -100.0% | +100.6% | -33.9% | >+9999.0% |
| alltime | all time | at high | +7666.7% | -100.0% | +100.6% | -33.9% | >+9999.0% |
Bicycle Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $519.75 M(+107.9%) | $203.00 K(-100.6%) | $519.75 M(-0.0%) |
| Sep 2024 | - | -$31.93 M(-105.8%) | $519.93 M(-33.9%) |
| Jun 2024 | - | $549.61 M(>+9900.0%) | $786.49 M(+215.6%) |
| Mar 2024 | - | $1.87 M(+384.7%) | $249.18 M(-0.3%) |
| Dec 2023 | $250.03 M(+3636.2%) | $386.00 K(-99.8%) | $250.03 M(-2.2%) |
| Sep 2023 | - | $234.63 M(+1808.8%) | $255.53 M(+1113.5%) |
| Jun 2023 | - | $12.29 M(+352.2%) | $21.06 M(+135.0%) |
| Mar 2023 | - | $2.72 M(-53.8%) | $8.96 M(+33.9%) |
| Dec 2022 | $6.69 M(-97.9%) | $5.89 M(+3603.1%) | $6.69 M(-96.5%) |
| Sep 2022 | - | $159.00 K(-18.5%) | $191.47 M(-17.4%) |
| Jun 2022 | - | $195.00 K(-56.7%) | $231.76 M(-6.2%) |
| Mar 2022 | - | $450.00 K(-99.8%) | $247.12 M(-23.0%) |
| Dec 2021 | $320.73 M | $190.66 M(+371.4%) | $320.73 M(+143.3%) |
| Sep 2021 | - | $40.45 M(+160.1%) | $131.81 M(-13.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $15.55 M(-79.0%) | $152.44 M(+11.4%) |
| Mar 2021 | - | $74.06 M(+4146.5%) | $136.90 M(+117.8%) |
| Dec 2020 | $62.84 M(+7.5%) | $1.74 M(-97.1%) | $62.84 M(+2.6%) |
| Sep 2020 | - | $61.09 M(>+9900.0%) | $61.22 M(-9143.0%) |
| Jun 2020 | - | $10.00 K(+400.0%) | -$677.00 K(-101.2%) |
| Mar 2020 | - | $2000.00(-98.4%) | $58.41 M(-0.1%) |
| Dec 2019 | $58.44 M(+129.8%) | $122.00 K(-115.0%) | $58.44 M(-30.2%) |
| Sep 2019 | - | -$811.00 K(-101.4%) | $83.75 M(-1.0%) |
| Jun 2019 | - | $59.09 M(>+9900.0%) | $84.56 M(+232.1%) |
| Mar 2019 | - | $34.00 K(-99.9%) | $25.46 M(+0.1%) |
| Dec 2018 | $25.43 M(-56.1%) | $25.43 M(>+9900.0%) | $25.43 M(>+9900.0%) |
| Sep 2018 | - | $1000.00(>+9900.0%) | $1000.00(>+9900.0%) |
| Jun 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2018 | - | $0.00 | $0.00 |
| Dec 2017 | $57.88 M | - | - |
FAQ
- What is Bicycle Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Bicycle Therapeutics?
- What is Bicycle Therapeutics annual CFF year-on-year change?
- What is Bicycle Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Bicycle Therapeutics?
- What is Bicycle Therapeutics quarterly CFF year-on-year change?
- What is Bicycle Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Bicycle Therapeutics?
- What is Bicycle Therapeutics TTM CFF year-on-year change?
What is Bicycle Therapeutics annual cash flow from financing activities?
The current annual CFF of BCYC is $519.75 M
What is the all time high annual CFF for Bicycle Therapeutics?
Bicycle Therapeutics all-time high annual cash flow from financing activities is $519.75 M
What is Bicycle Therapeutics annual CFF year-on-year change?
Over the past year, BCYC annual cash flow from financing activities has changed by +$269.72 M (+107.88%)
What is Bicycle Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of BCYC is $203.00 K
What is the all time high quarterly CFF for Bicycle Therapeutics?
Bicycle Therapeutics all-time high quarterly cash flow from financing activities is $549.61 M
What is Bicycle Therapeutics quarterly CFF year-on-year change?
Over the past year, BCYC quarterly cash flow from financing activities has changed by -$549.40 M (-99.96%)
What is Bicycle Therapeutics TTM cash flow from financing activities?
The current TTM CFF of BCYC is $519.75 M
What is the all time high TTM CFF for Bicycle Therapeutics?
Bicycle Therapeutics all-time high TTM cash flow from financing activities is $786.49 M
What is Bicycle Therapeutics TTM CFF year-on-year change?
Over the past year, BCYC TTM cash flow from financing activities has changed by -$266.74 M (-33.92%)